Expert Opinion on Orphan Drugs Impact Factor in Pharmaceutics Journals

Expert Opinion on Orphan Drugs in Pharmaceutics Journals

Journal Country: United Kingdom
Journal Q tier: Q2
Publishing Firm: Taylor and Francis Ltd.
History: 2013-2022
Journal Homepage: ----
Journal ISSN: 21678707

Research Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3); Health Policy (Q4)

Impact Score: 0.71
h-Index: 25
SJR: 0.238
Ranking: 17341

About Expert Opinion on Orphan Drugs

Expert Opinion on Orphan Drugs is a journal covering the technologies/fields/categories related to Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3); Health Policy (Q4). It is published by Taylor and Francis Ltd.. The overall rank of Expert Opinion on Orphan Drugs is 17341.According to SCImago Journal Rank (SJR), this journal is ranked 0.238. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 25. The best quartile for this journal is Q2.The ISSN of Expert Opinion on Orphan Drugs journal is 21678707.An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Expert Opinion on Orphan Drugs is cited by a total of 95 articles during the last 3 years (Preceding 2022).

Log in to add a review. Log in

No reviews yet. Be the first to review this journal.